Study design

prospective

Study time

2006.5-2019.12

Country

Germany

Object

consecutive patients with PCa were identified, who had complete pathological data and were treated with RARP and extended pelvic lymph node dissection

Inclusion criteria

Patients with suspected metastases were excluded

Sample size

4235

Topic classification

Special populations

Keypoint

Approximately every second senior patient has a misclassification in (i.e., any up or downgrade) and each 4.5th senior patient specifically has an upgrade in his fil pathology that directly translates to an unfavorable PCa prognosis.

Year